Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

3 FTSE 100 Shares That the Market Loves: Rio Tinto plc (ADR) (RIO) and More

LONDON — I used a market statistics package to find the FTSE 100 companies that were most recommended as “buys” among professional market analysts. Here are three shares that they are in love with.


Melrose is a conglomerate that has grown through the acquisition and sale of industrial and manufacturing companies. It first came to the market in 2003. Since then, it has grown from a company with a 13 million pound market capitalization to being a member of the FTSE 100 index today.

The confidence that the analyst community has in Melrose’s management has inspired a swathe of buy recommendations on the stock.

Earnings per share (EPS) is forecast to grow 8.5% during 2013, meaning that the shares trade on a forward price-to-earnings (P/E) ratio of 13.7 times expectations. The dividend is also expected to rise by just over 6%. That equates to a value that is in line with the average for a FTSE 100 company.

A Deeper Look at South Africa’s Commodity IndustryRio Tinto plc (ADR) (NYSE:RIO) (LSE:RIO)

Diversified mining company Rio Tinto plc (ADR) (NYSE:RIO) is forecast to increase EPS by 13% for 2013, followed by an 11.9% rise in 2014. Despite this optimism, the shares today trade on just 9.4 times the 2013 forecast, falling to 8.4 times for 2014.

The market’s enthusiasm for the shares seems to have inspired a more than 20% rally since the beginning of December. The dividend yield on the shares is expected to reach 2.9% for 2013, rising to 3.3% for 2014.

The shares look like an excellent way to gain exposure to the mining sector while still receiving income.


Shire is a pharmaceutical company with a strong presence in the ADD (Attention Deficit Disorder) market.

Shire has delivered the kind of growth that its larger peers GlaxoSmithKline plc (ADR) (NYSE:GSK) and AstraZeneca plc (ADR) (NYSE:AZN) can only dream of. Between 2006 and 2011, EPS increased more than threefold. In the last five years, dividends at the company have increased by an average of 13.2% per year.

Shire is expected to report a 27.5% increase in EPS for 2012, followed by another 9.3% rise for 2013. The shares trade on a 2013 P/E of 14.2 times earnings.

Although Shire is a great example of a growth company on the market today, our analysts here at The Motley Fool think that they have found an even better opportunity. Although the company in question is long established, it is quickly moving to take a leading role in new markets.

The article 3 FTSE 100 Shares That the Market Loves originally appeared on and is written by David O’Hara.

David O’Hara has no position in any stocks mentioned, and neither does The Motley Fool. Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.